Loading…
This event has ended. Create your own event on Sched.
Welcome to the Science Summit at UNGA76, a major contribution to advancing Science for the UN SDGs. Online from 14- September - 5 October 2021.
ISC will organise the second edition of the UNGA76 Science Summit around the 76th United Nations General Assembly (SSUNGA76) in September 2021. The objective of the virtual meeting will be to raise awareness of the role and contribution of science to the attainment of the United Nations Sustainable Development Goals. It will demonstrate initiatives that provide models for global science mechanisms and activities in support of the SDGs, particularly in science infrastructure and capacity building. Science is and will enable sustainable economic, environmental, and societal development. Science is more than a funding prioritisation exercise: science is impacting all areas of policy-making and is playing a more critical role in how policy objectives are achieved and the consequent benefit to people everywhere, including responses to global challenges.
Engagement with policy leadership is more important than ever: UNGA76 is a unique forum for science to demonstrate how policy and political leadership can benefit from innovation. Central to this is the role of nonstate actors and the multilateral fora, which increasingly determine how priorities are set. Science needs to be part of this dialogue and inform outputs through thought leadership, evidence, insights, analysis, and innovation.

Registration is available here.
avatar for Erik Ruuth

Erik Ruuth

IMiBio
Scientific Coordinator
Puerto Iguazú, Misiones, Argentina
Erik Ruuth, M.D., PH.D., Ass. Prof. is a medical doctor with a Ph.D. in immunology and an adjunct professor in cell and molecular biology at Umeå University.

After completing a postdoc at Hôpital Necker Enfants Malades in Paris, France, Erik made a career within the pharmaceutical industry covering areas ranging from basic industrial research to the molecular activities of new active principles, discoveries of mechanisms of action, preclinical development phases, clinical studies for registry, for authorities such as the FDA and EMA, ranging from PhI to III and post-marketing studies (PhIV). He assumed a number of responsibilities, as head of global research projects, head of EU therapeutic areas for anti-infectives, respiratory system and central nervous system products, head of development programs, expert in global products, project leader global research leader and leader of different types from PhI to PhIII clinical trials. As a consultant, ER has worked for the Ministry of Science and Technology of Argentina, for the National Cancer Institute in a large breast cancer project, consultant for the pharmaceutical and biotechnology industry. He is currently senior scientific advisor at the Madariaga Hospital in Posadas (Misiones), Principal Investigator at the Faculty of Medicine of the Catholic University of Misiones and Scientific Coordinator of the Misiones Institute for Biodiversity.
Tuesday, September 14
 

12:00pm CEST

2:30pm CEST

 
Wednesday, September 15
 

10:00am CEST

3:00pm CEST

 
Thursday, September 16
 

5:00pm CEST

 
Monday, September 20
 

3:00pm CEST

 
Tuesday, September 21
 

3:00pm CEST

 
Wednesday, September 22
 

3:00pm CEST

5:00pm CEST

 
Thursday, September 23
 

10:00am CEST

 
Monday, September 27
 

3:00pm CEST

5:00pm CEST

 
Tuesday, September 28
 

3:00pm CEST

6:30pm CEST

 
Wednesday, September 29
 

9:00am CEST

10:00am CEST

 
Thursday, September 30
 

10:00am CEST

 
Friday, October 1
 

1:00pm CEST

 
Thursday, October 14
 

3:00pm CEST